EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Identifying a predictive level of serum C-terminal telopeptide associated with a low risk of medication-related osteonecrosis of the jaw secondary to oral surgery: A systematic review and meta-analysis

Camille Ghio iD, Robinson Gravier-Dumonceau, Pierre Lafforgue, Roch Giorgi, Thao Pham iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0318260 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift PLOS One, 2025. Verfasst von Camille Ghio und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Aix Marseille Univ, APHM, Hôpital Sainte-Marguerite, Marseille, France. Hauptthemen laut MEDLINE: Collagen Type I, Peptides, Bisphosphonate-Associated Osteonecrosis of the Jaw, Surgery, Oral. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Our aim was to determine serum C-terminal telopeptide of type I collagen (sCTX) thresholds for predicting the minimal risk of medication-related osteonecrosis of the jaw (MRONJ) in patients undergoing anti-resorptive therapy prior to oral surgery.

Methods

A systematic literature search was conducted in MEDLINE, EMBase, and the Cochrane Library up to September 2023 for case-control, prospective and retrospective studies that assessed sCTX levels in patients exposed to anti-resorptive drugs who underwent oral surgery. We extracted data using a predetermined form. We performed an original percentile meta-analysis method, following PRISMA-DTA guidelines and descriptive analysis to identify the threshold associated with the lowest risk while assessing the overall result of the 95 th , 97.5 th and 99 th percentiles with a random-effect model with weighting by DerSimonian and Laird (RStudio software [v. 4.2.0]).

Results

Seven studies involving 1281 patients were included. Most patients (96%) were treated for osteoporosis, predominantly with oral bisphosphonates (94.5%). Individual data were available for 58 patients. In the entire population of patients who experienced MRONJ after oral surgery (n = 113), the 95 th , 97.5 th and 99 th percentiles of sCTX were 338.0 pg/mL [95%CI: 190,3; 485,7], 401.9 pg/mL [95%CI: 191,3; 612,6], and 458.0 pg/mL [95%CI: 190,4; 725,6], respectively. Among those treated with oral bisphosphonates for osteoporosis (n = 38), the sCTX 95 th , 97.5 th and 99 th percentiles were 185.3 pg/mL [95%CI: 131,3; 239,3] 187.4 pg/mL [95%CI: 133,9; 240,8] and 188.6 pg/mL [95%CI: 135,4; 241,9], respectively. The determination of these same percentiles with individual data analysis yielded similar results, i.e., 202.0, 257.0 and 260.0 pg/mL.

Conclusion

This pioneering meta-analysis assesses the risk of MRONJ by analyzing sCTX levels in patients undergoing oral surgery while exposed to antiresorptive drugs. Among patients receiving oral bisphosphonate therapy for osteoporosis, a sCTX threshold of 260 pg/mL is linked to an extremely low risk of MRONJ occurrence, surpassing the 99 th percentile. Conversely, for patients undergoing treatment for cancer-related conditions, sCTX levels do not reliably serve as a biomarker for identifying this risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Collagen Type IPeptidesBisphosphonate-Associated Osteonecrosis of the JawSurgery, OralOral Surgical ProceduresHumansBone Density Conservation AgentsOsteoporosisDiphosphonatesRisk Factors

Substanzen

collagen type I trimeric cross-linked peptideCollagen Type IPeptidesBone Density Conservation AgentsDiphosphonates

Autor:innen und Institutionen

  • Department of Rheumatology, Aix Marseille Univ, APHM, Hôpital Sainte-Marguerite, Marseille, France.
  • Aix Marseille Univ, APHM, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Hop Timone, BioSTIC, Biostatistique et Technologies de l'Information et de la C…

ORCID-Profile: Camille Ghio, Thao Pham

Zitieren

APA

Ghio, C., Gravier-Dumonceau, R., Lafforgue, P., Giorgi, R., & Pham, T. (2025). Identifying a predictive level of serum C-terminal telopeptide associated with a low risk of medication-related osteonecrosis of the jaw secondary to oral surgery: A systematic review and meta-analysis. PLOS One. https://doi.org/10.1371/journal.pone.0318260

Vancouver

Ghio C, Gravier-Dumonceau R, Lafforgue P, Giorgi R, Pham T. Identifying a predictive level of serum C-terminal telopeptide associated with a low risk of medication-related osteonecrosis of the jaw secondary to oral surgery: A systematic review and meta-analysis. PLOS One. 2025. doi:10.1371/journal.pone.0318260

BibTeX
@article{Ghio2025,
  author = {Ghio, Camille and Gravier-Dumonceau, Robinson and Lafforgue, Pierre and Giorgi, Roch and Pham, Thao},
  title = {Identifying a predictive level of serum C-terminal telopeptide associated with a low risk of medication-related osteonecrosis of the jaw secondary to oral surgery: A systematic review and meta-analysis},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0318260}
}
Kostenlos starten →